Used in research and development for targeting TrkA (Tropomyosin receptor kinase A), this antibody serves as a reference tool in immunoassays and binding studies. It helps characterize TrkA expression in cells and tissues, supporting studies in neurobiology and pain signaling pathways. Due to TrkA’s involvement in certain cancers and inflammatory conditions, the antibody aids in evaluating target engagement and specificity of therapeutic agents. It is also employed in pharmacokinetic and pharmacodynamic studies during preclinical development of drugs targeting the NTRK1 pathway.